ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · IEX Real-Time Price · USD
2.290
-0.090 (-3.78%)
At close: Mar 28, 2024, 3:59 PM
2.420
+0.130 (5.68%)
After-hours: Mar 28, 2024, 7:58 PM EDT

ProQR Therapeutics Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013
Revenue
9.534.362.389.451.935.761.51.833.240.31
Upgrade
Revenue Growth (YoY)
118.51%83.31%-74.84%388.98%-66.45%285.35%-18.22%-43.49%933.55%169.83%
Upgrade
Gross Profit
9.534.362.389.451.935.761.51.833.240.31
Upgrade
Selling, General & Admin
16.2418.6517.3713.6912.8912.5410.849.486.846.51
Upgrade
Research & Development
25.1550.8742.2238.1446.4929.5131.1531.9223.410.27
Upgrade
Operating Expenses
41.3869.5259.5951.8259.3842.0541.9941.430.2416.77
Upgrade
Operating Income
-31.86-65.16-57.21-42.37-57.45-36.29-40.5-39.57-27-16.46
Upgrade
Interest Expense / Income
1.465.133.414.031.080.793.18-0.47-6.17-4.33
Upgrade
Other Expense / Income
-5.12-5.960.010.04-2.18-0.19-0.04---
Upgrade
Pretax Income
-28.2-64.33-60.62-46.44-56.35-36.89-43.64-39.1-20.83-12.13
Upgrade
Income Tax
-0.080.10.120.120.1300000
Upgrade
Net Income
-28.12-64.42-60.74-46.57-56.48-36.89-43.64-39.1-20.83-12.13
Upgrade
Shares Outstanding (Basic)
81726450413425232311
Upgrade
Shares Outstanding (Diluted)
81726450413425232311
Upgrade
Shares Change
13.08%11.62%28.21%21.99%20.51%34.20%8.69%0.01%110.63%100.86%
Upgrade
EPS (Basic)
-0.35-0.90-0.95-0.93-1.38-1.08-1.72-1.67-0.89-1.09
Upgrade
EPS (Diluted)
-0.35-0.90-0.95-0.93-1.38-1.08-1.72-1.67-0.89-1.09
Upgrade
Free Cash Flow
28.18-69.21-26.44-47-45.17-28.93-35.22-36.76-25.53-15.57
Upgrade
Free Cash Flow Per Share
0.35-0.97-0.41-0.94-1.10-0.85-1.39-1.57-1.09-1.41
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-334.48%-1494.82%-2405.80%-448.24%-2971.81%-629.98%-2708.90%-2164.82%-834.71%-5259.11%
Upgrade
Profit Margin
-295.21%-1477.95%-2554.25%-492.65%-2921.88%-640.41%-2918.86%-2139.11%-643.96%-3874.44%
Upgrade
Free Cash Flow Margin
295.82%-1587.75%-1111.73%-497.21%-2336.83%-502.24%-2355.65%-2010.94%-789.12%-4973.16%
Upgrade
EBITDA
-24.23-56.68-54.89-40.06-53.21-35.11-39.4-38.33-26.52-16.34
Upgrade
EBITDA Margin
-254.34%-1300.30%-2308.20%-423.79%-2752.87%-609.43%-2635.12%-2096.72%-819.88%-5218.85%
Upgrade
Depreciation & Amortization
2.512.522.332.362.050.991.071.250.480.13
Upgrade
EBIT
-26.74-59.2-57.22-42.41-55.27-36.1-40.46-39.57-27-16.46
Upgrade
EBIT Margin
-280.72%-1358.13%-2406.14%-448.71%-2859.03%-626.64%-2706.35%-2164.82%-834.71%-5259.11%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).